It is somewhat surprising, therefore, that the effectiveness of neither protein has been investigated using overexpression, transfection or prolonged delivery approaches, as has occurred for neurotrophins, since they represent an appealing strategy for prolonging RGC survival in glaucoma. The gene discussed is BDNF; the disease is glaucoma.